640 related articles for article (PubMed ID: 28290112)
1. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.
Zhang Y; Milojevic D
Paediatr Drugs; 2017 Jun; 19(3):193-211. PubMed ID: 28290112
[TBL] [Abstract][Full Text] [Related]
2. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
[TBL] [Abstract][Full Text] [Related]
3. Bone health in pediatric rheumatic disease.
Rouster-Stevens KA; Klein-Gitelman MS
Curr Opin Pediatr; 2005 Dec; 17(6):703-8. PubMed ID: 16282774
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
Furia FF; Godfrey E; Mwamanenge N; Swai P
Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
[TBL] [Abstract][Full Text] [Related]
5. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.
LeBlanc CM; Ma J; Taljaard M; Roth J; Scuccimarri R; Miettunen P; Lang B; Huber AM; Houghton K; Jaremko JL; Ho J; Shenouda N; Matzinger MA; Lentle B; Stein R; Sbrocchi AM; Oen K; Rodd C; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Rauch F; Siminoski K; Ward LM;
J Bone Miner Res; 2015 Sep; 30(9):1667-75. PubMed ID: 25801315
[TBL] [Abstract][Full Text] [Related]
6. Bone safety of low-dose glucocorticoids in rheumatic diseases.
Saag KG
Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.
Alsufyani KA; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Nadel H; Malleson PN
J Rheumatol; 2005 Apr; 32(4):729-33. PubMed ID: 15801032
[TBL] [Abstract][Full Text] [Related]
8. The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature.
Huber AM; Ward LM
Semin Arthritis Rheum; 2016 Aug; 46(1):49-63. PubMed ID: 27020068
[TBL] [Abstract][Full Text] [Related]
9. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
10. Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids.
Harrington J; Holmyard D; Silverman E; Sochett E; Grynpas M
Pediatr Rheumatol Online J; 2016 Nov; 14(1):58. PubMed ID: 27832795
[TBL] [Abstract][Full Text] [Related]
11. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study.
Rodd C; Lang B; Ramsay T; Alos N; Huber AM; Cabral DA; Scuccimarri R; Miettunen PM; Roth J; Atkinson SA; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Larché M; LeBlanc C; Oen K; Saint-Cyr C; Stein R; Stephure D; Taback S; Lentle B; Matzinger M; Shenouda N; Moher D; Rauch F; Siminoski K; Ward LM;
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):122-31. PubMed ID: 22213727
[TBL] [Abstract][Full Text] [Related]
12. [Bone density in children and adolescents with rheumatic diseases. Preliminary results of selective measurement of trabecular and cortical bone using peripheral computerized tomography].
Lettgen B; Neudorf U; Hosse R; Peters S; Reiners C
Klin Padiatr; 1996; 208(3):114-7. PubMed ID: 8676598
[TBL] [Abstract][Full Text] [Related]
13. Management of osteoporosis in rheumatoid arthritis patients.
Hoes JN; Bultink IE; Lems WF
Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
Said MA; Silva LSTE; de Oliveira Rocha AM; Alves GGB; Piotto DGP; Len CA; Terreri MT
Adv Rheumatol; 2020 Nov; 60(1):53. PubMed ID: 33153496
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.
von Scheven E; Corbin KJ; Stagi S; Cimaz R
Curr Osteoporos Rep; 2014 Sep; 12(3):289-99. PubMed ID: 25001898
[TBL] [Abstract][Full Text] [Related]
16. [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment].
Di Munno O; Delle Sedie A
Reumatismo; 2006; 58(1):11-21. PubMed ID: 16639483
[TBL] [Abstract][Full Text] [Related]
17. [Fractures and bone mineral density in childhood].
Hofmann C; Girschick H; Lapa C; Semler O; Jakob F
Z Rheumatol; 2019 Sep; 78(7):636-644. PubMed ID: 31338681
[TBL] [Abstract][Full Text] [Related]
18. Fracture risk in systemic lupus erythematosus patients over 28 years.
Garelick D; Pinto SM; Farinha F; Pires T; Khan E; Isenberg D
Rheumatology (Oxford); 2021 Jun; 60(6):2765-2772. PubMed ID: 33221918
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
20. [Secondary forms of osteoporosis. Special features of diagnostics in childhood and adolescence].
Stark C; Hoyer-Kuhn H; Knoop K; Schoenau H; Schoenau E; Semler O
Z Rheumatol; 2014 May; 73(4):335-41. PubMed ID: 24714928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]